PAVmed Inc. (PAVM) stock
PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$1.51−0.24 (-13.71%)
Close on Nov 17, 2026Market cap $12.07MP/E –Yield –
PAVmed operating margin
Operating margin is operating income as a percentage of revenue.
PAVmed's operating margin for the twelve months ending Jun 30, 2026 was -23842.9%. For fiscal 2025 it was -30712.7%, against -1485.4% the year before. The highest annual figure on record is -1485.4% in fiscal 2024.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -30712.7% | −29227.3 |
| FY2024 | Dec 31, 2024 | -1485.4% | +1320.3 |
| FY2023 | Dec 31, 2023 | -2805.7% | +21355.3 |
| FY2022 | Dec 31, 2022 | -24161.0% | −13282.4 |
| FY2021 | Dec 31, 2021 | -10878.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -21278.8% | +57304.5 |
| Q1 FY2026 | Mar 31, 2026 | -36522.7% | +31552.3 |
| Q4 FY2025 | Dec 31, 2025 | -13082.7% | +38787.3 |
| Q3 FY2025 | Sep 30, 2025 | -96880.0% | −95717.6 |
| Q2 FY2025 | Jun 30, 2025 | -78583.3% | −77185.6 |
| Q1 FY2025 | Mar 31, 2025 | -68075.0% | −66685.3 |
| Q4 FY2024 | Dec 31, 2024 | -51870.0% | −50308.2 |
| Q3 FY2024 | Sep 30, 2024 | -1162.4% | +800.6 |
| Q2 FY2024 | Jun 30, 2024 | -1397.8% | +8532.4 |
| Q1 FY2024 | Mar 31, 2024 | -1389.7% | +3184.5 |
| Q4 FY2023 | Dec 31, 2023 | -1561.8% | +20403.4 |
| Q3 FY2023 | Sep 30, 2023 | -1963.1% | +28783.0 |
| Q2 FY2023 | Jun 30, 2023 | -9930.1% | +458.8 |
| Q1 FY2023 | Mar 31, 2023 | -4574.2% | +1985.5 |
| Q4 FY2022 | Dec 31, 2022 | -21965.2% | −15131.2 |
| Q3 FY2022 | Sep 30, 2022 | -30746.1% | – |
| Q1 FY2022 | Mar 31, 2022 | -10388.9% | – |
| Q4 FY2021 | Dec 31, 2021 | -6559.7% | – |
| Q3 FY2021 | Sep 30, 2021 | -6834.0% | – |
See a number that looks wrong?